Benefit management for high-cost drugs, internalization of regulatory-reimbursement linkage system and cost-effectiveness exemption system
A policy proposal has emerged suggesting the need to strengthen the regulatory and reimbursement linkage system and urgently improve the cost-effec...
Read more